Novel compound, organic cation transporter 3 detection agent and organic cation transporter 3 activity inhibitor, WO2015002150 A1: a patent evaluation.

about

Novel compound, organic cation transporter 3 detection agent and organic cation transporter 3 activity inhibitor, WO2015002150 A1: a patent evaluation.

Item

http://www.wikidata.org/entity/Q38878584

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Novel compound, organic cation ...... 02150 A1: a patent evaluation.

@en

type

Item

label

Novel compound, organic cation ...... 02150 A1: a patent evaluation.

@en

prefLabel

Novel compound, organic cation ...... 02150 A1: a patent evaluation.

@en

P1476

Novel compound, organic cation ...... 02150 A1: a patent evaluation.

@en

P2093

Hualin Qi

http://www.w3.org/2001/XMLSchema#string

Li Wang

http://www.w3.org/2001/XMLSchema#string

Tao Hu

http://www.w3.org/2001/XMLSchema#string

Xiaolei Pan

http://www.w3.org/2001/XMLSchema#string

P2860

Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3

OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies

Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain

Membrane transporters in drug development

Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: a network meta-analysis.

Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.

Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3

Interaction of organic cations with a newly identified plasma membrane monoamine transporter.

Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).

Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics.

P304

857-860

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543776.2016.1180364

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27097290

http://www.w3.org/2001/XMLSchema#string